• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

3v.org

Venture Capital Matters

  • Pitch a Startup
    • Make a Contribution
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

iSTAR Medical Announces EUR 40m Series C Financing

September 5, 2019 By admin Leave a Comment

iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and Gimv, with participation by Earlybird and BNP Paribas Fortis Private Equity. Existing shareholders including Capricorn Partners, Walloon Region Investment Fund (SRIW) and Belgian Federal Investment Fund (SFPI‐FPIM) also participated. This financing will support the development of iSTAR Medical’s MINIjectTM device along the path to commercialisation in Europe and the United States.

Glaucoma is the second leading cause of adult blindness globally affecting more than 92 million people. Micro-invasive glaucoma surgery (MIGS) is the most promising and fastest-growing therapeutic option in the treatment of glaucoma[1].

Michel Lussier, Chairman of the Board of Directors at iSTAR Medical, said: “We are delighted to welcome LSP, Gimv, Earlybird and BNP Paribas Fortis Private Equity to iSTAR Medical, and I would like to thank our existing investors for their continued support. This renowned investor syndicate has a track record of supporting successful, innovative companies and is a strong endorsement of our world-leading technology for glaucoma sufferers.”

MINIject, an ab-interno MIGS device, provides a powerful and reliable solution to safely reduce intraocular pressure (IOP) by enhancing aqueous humour outflow from the anterior chamber to the supraciliary space, and has been designed to be a best-in-class MIGS device. Unlike other technologies, MINIject uses the innovative STAR® material, a soft and flexible, medical-grade silicone with a micro-porous, multi-channel geometry.

Data from the first-in-human STAR-I trial for the MINIject device in a standalone setting confirm that MINIject is safe and highly effective in achieving significant IOP reduction, as well as easing medication burden in glaucoma patients.

Michel Vanbrabant, CEO of iSTAR Medical, commented: “iSTAR Medical is setting new frontiers in MIGS treatment of glaucoma. The positive results achieved at 18-month follow-up of our first-in-human trial validates the potential of MINIject in the supraciliary space as the next therapeutic option for glaucoma patients. This financing is a significant milestone for the company and will support the development and commercial launch of MINIject.”

In conjunction with the financing, Anne Portwich (LSP), Bram Vanparys (Gimv), and Lionel Carnot (Earlybird) will be joining the Board of Directors at iSTAR Medical.

Bram Vanparys, Partner at Gimv, commented on the news: “We are looking forward to help build iSTAR Medical to become the leading player in the MIGS field. With the support and expertise of a solid, specialized Life Science syndicate, iSTAR Medical now has all the tools to leverage and expand the excellent clinical results of MINIject.”

Anne Portwich, Partner at LSP, added: “Minimally Invasive Glaucoma Surgery promises to revolutionise the treatment of glaucoma. We are very pleased to lead the investment in iSTAR Medical. MINIject’s innovative design and novel material, combined with the impressive clinical data from the STAR-I trial, demonstrate the potential of this device. We look forward to supporting the experienced management team as it progresses towards the commercialisation of MINIject in Europe and plans for the upcoming US pivotal trial.”

Early six-month results of MINIject in the STAR-I trial were published online in June 2019 in Ophthalmology-Glaucoma, the journal of the American Glaucoma Society (AGS). The 18-month results of MINIject will be presented in detail on Friday, 13 September 2019, during Glaucoma Day at the ESCRS congress in Paris, France.

About iSTAR Medical SA

iSTAR Medical SA, headquartered in Wavre, Belgium, is a private, clinical-stage, medical technology company focused on the development of novel ophthalmic implants for glaucoma.

Glaucoma is the second leading cause of adult blindness globally, affecting more than 92 million people worldwide. Micro-invasive glaucoma surgery (MIGS) is the most promising and fastest-growing therapeutic option in the treatment of glaucoma. iSTAR has exclusive rights to the STAR® biomaterial from the University of Washington in Seattle (USA) for ophthalmic use. This provides the foundation for the development of MINIjectTM, designed to be a best-in-class MIGS device. The fast-growing MIGS market is expected to reach $1.1bn worldwide by 2023 (MarketScope 2018 Glaucoma Surgical Device Report).

iSTAR Medical’s management team and board have a successful track record in end-to-end product development, with proven clinical, regulatory and market access capabilities. The company is backed by specialised institutional and private investors. For more information, please go to www.istarmed.com

Filed Under: PR Tagged With: iSTAR Medical, ophthalmic

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

Australia approves a drought-tolerant genetically modified strain of wheat for use in food
Market Impact of Trade War on Chinese High Tech Industries
Portuguese wine market is booming
Net Zero Balance Technologies That Could Make a Difference
Top U.S. defense contractors are competing for contracts on hypersonic weapons
The construction industry is responsible for 11% of the world’s man-made carbon emissions
3G Networks are Dead

Market Research Media

Inflation Bites: The U.S. government can buy fewer infrastructure today
RealityCheckout.com (Reality Checkout): How do the past tech predictions fare?
Resilient Supplies: AI is the name of the game
Top technology, media, and telecommunications (TMT) companies for total shareholder return (TSR)
VisualMediaMarket.com: Visual Media Market
Global asset classes compared by market cap in 2021
Two biggest barriers to wider adoption of XR are user experience and limited content

Secondary Sidebar

Technologies

Energy Dome Successfully Launches First CO2 Battery Long-Duration Energy Storage Plant in the World
Universal Hydrogen Inaugurates Engineering Design Center and European Headquarters in Toulouse, France
2021 JavaScript developer roadmap
French company captures methane leaking from abandoned mines
The global tech industry will become an even more dynamic opportunity for PE investors

Tech Events

IEEE SERVICES 2021, the premier international computing and applications event, taking place 5-10 September 2021
NVIDIA GPU Technology Conference, October 5-9, 2020
DTX Europe 2021 taking place at the ExCeL London from 6-7 October 2021
COMPUTEX 2021 Virtual is now live through June 30
IEEE International Conference on Quantum Computing and Engineering, 18-23 September 2022, Broomfield, Colorado

Footer

Recent Posts

  • Breakthrough VR Basketball App Gym Class Closes $8 Million in Seed Round Led by Andreessen Horowitz
  • Techstars and Audi Launch Pre-Accelerator Program to Promote Innovation in Mobility
  • Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow
  • Seedtag raises over €250M from Advent International
  • Arable Raises $40 Million to Accelerate Sustainable Agriculture
  • European Quantum Computing Leader IQM Raises €128m Led by World Fund to Help Combat the Climate Crisis
  • Whatnot raises $260M Series D co-led by DST Global and CapitalG to expand its live, social commerce marketplace
  • ZeroAvia Secures Additional $30 Million in Funding from IAG, Barclays, NEOM & AENU
  • Medusa Raises $8m to Build the Leading E-Commerce Platform for Developers
  • Blue Ocean Barns Completes $20 Million Series A Financing, Accelerating Solution to Agricultural Methane Emissions

Dossier

Xilinx Acquires Silexica to Broaden its Developer Base
MPCC orders two carbon-neutral 1,300 TEU newbuildings in partnership with industrial group Elkem and North Sea Container Line
ZoomInfo to Acquire Conversation Intelligence Leader Chorus.ai to Enable Insight-Driven Targeting, Coaching, and Decision-Making for Go-to-Market Teams
Fitch downgraded Turkey’s sovereign debt rating further into junk
Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

Press Media Release

NASA to Discuss Status of Artemis I Moon Mission
Legalization of Marijuana Linked to Increased Traffic Crashes, Fatalities
The Salvation Army and Convoy of Hope Partner Together to Meet the Needs of Ukrainian Refugees
Morabito Consultants Issues Statement on Building Collapse in Surfside, Fla.
American Association of Nurse Practitioners Applauds Approval of COVID-19 Vaccine; Urges Public to Get Vaccinated

App Coding

Code Intelligence raises $12M Series A
Ondat 2.8 Arrives in GA with Increased Support for Stateful Workloads in Kubernetes
Writing code on the fly
Scrub your code in real-time
Datadog Named a Leader in the 2022 Gartner® Magic Quadrant™ for Application Performance Monitoring and Observability

API Coding

Fintech AI Leader Photon Commerce Partners With Identifee to Enable Banks to Instantly Digitize and Analyze Statements
LeadDev London! The event for engineering leaders
Types of API Testing
What is a REST API?
What is an API Gateway?

Copyright © 2022 3v.org

Technologies, Market Analysis & Market Research

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT